PLSMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Pulsenmore Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 30, 2026
$1.78−0.09 (-4.81%)
Close on Oct 19, 2026
Ownership
Who owns Pulsenmore's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Aquamarine Financial (Cayman) Ltd | 338,541 | 5.02% | 13G (passive) | Mar 31, 2026 |
| Elazar Sonnenschein | 1,872,092 | 28.79% | 13G (passive) | Mar 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Elazar Sonnenschein | Chief Executive Officer, Director | 1,872,092 | 28.79% | Mar 18, 2026 |
| Eran Hirsh | Chief Financial Officer | – | – | Mar 18, 2026 |
| Michael Hamelsdorf | GC & Corporate Secretary | – | – | Mar 18, 2026 |
| Minelu Sonnenschein | VP R&D | – | – | Mar 18, 2026 |
| Meir Shmouely | VP Software Development | 13,812 | 0.21% | Mar 18, 2026 |
| Jonathan Adereth | Director | 129,062 | 1.98% | Mar 18, 2026 |
| Racheli Guz-Lavi | Director | – | – | Mar 18, 2026 |
| Anat Loewenstein | Director | – | – | Mar 18, 2026 |
| Hagai Itkin | Director | – | – | Mar 18, 2026 |
| Linda Messalem | Director | – | – | Mar 18, 2026 |